have very ambitious valuations but the potential upside (in mergers and, fundamentally in food, drink, supplemental and medical applications) are undeniably immense. The view of a possible rapid rise in revenues and profits (albeit from a low base) provide the chance for rather steep upside opportunities and the possibility that the speculative fervor (that has characterized the pot space over the last few years) may be resuscitated again sometime in 2019.